All Stories

  1. Drug repurposing for the interplay between Parkinson’s disease and epilepsy
  2. Adipose-derived mesenchymal stem cells improved acute renal failure induced by ischemia–reperfusion injury: Focusing on toll-like receptor 4 activity and endoplasmic reticulum stress response
  3. Palmatine enhances osteogenesis in hADMSCs via antioxidant enzyme upregulation and early RUNX2 activation
  4. Characterization of sensory nerve conduction abnormalities at the time of ALS diagnosis
  5. Hippocampal Vascularization Patterns and Its Role in Vascular Impairment
  6. Unveiling the Therapeutic Potential of Small Molecule of SVAK-12: A Comprehensive In Silico, In Vitro, and In Vivo Studies on its Neuroprotective Effects and Molecular Interactions in Parkinson's Disease
  7. Prenatal exposure to Bisphenol A sex-specifically disrupts prepulse inhibition and decreases parvalbumin-positive neurons in the prefrontal cortex of adult rats
  8. Comparative analysis of β-Estradiol and testosterone on lipid droplet accumulation, and regulatory protein expression in palmitate/oleate-induced fatty HepG2 cells
  9. Sodium Phenylbutyrate and Tauroursodeoxycholic Acid: A Story of Hope Turned to Disappointment in Amyotrophic Lateral Sclerosis Treatment
  10. Uncovering the six-month impact of COVID-19 on acute ischemic stroke patients: A hospital cohort study
  11. Parkinson’s Disease and Epilepsy: A bioinformatics analysis
  12. Masitinib: The promising actor in the next season of the Amyotrophic Lateral Sclerosis treatment series
  13. Strong Binding of Phytochemicals to the Catalytic Domain of Tyrosine Hydroxylase as a Trojan Horse Decreases Dopamine in Dopaminergic Cells: Pharmaceutical Considerations in Schizophrenia and Parkinson’s Disease
  14. Modulation of autophagy by melatonin via sirtuins in stroke: From mechanisms to therapies
  15. Heart Failure Status among Acute Ischemic Stroke Patients: A Hospital-Based Study
  16. Co-delivery of curcumin and Bcl-2 siRNA to enhance therapeutic effect against breast cancer cells using PEI-functionalized PLGA nanoparticles
  17. Experimental in Vitro and in Vivo Models of Demyelinating Disorders
  18. Fingolimod Nanoemulsions at Different Particle Sizes Define the Fate of Spinal Cord Injury Recovery
  19. Chitosan: A versatile bio-platform for breast cancer theranostics
  20. Particle Size of Drug Nanocarriers Defines the Fate of Spinal Cord Injury’s Recovery
  21. Mesenchymal Stem Cell Therapies for Paraplegia: Preclinical and Clinical Studies
  22. Differentiation of Mesenchymal Stem Cells Derived From Human Adipose Tissue Into Cholinergic-like Cells; in vitro
  23. New Horizons in Hydrogels for Methotrexate Delivery
  24. Melatonin Regulates Neuroinflammation Ischemic Stroke Damage through Interactions with Microglia in Reperfusion phase
  25. Reactive Astrocyte Gliosis: Production of Inhibitory Molecules
  26. Evaluation of the neuroprotective effects of electromagnetic fields and coenzyme Q 10 on hippocampal injury in mouse
  27. Small molecule of sphingosine as a rescue of dopaminergic cells: A cell therapy approach in neurodegenerative diseases therapeutics
  28. Intra-arterial Drug Delivery to the Ischemic Brain in Rat Middle Cerebral Artery Occlusion Model
  29. Human Endometrial Stem Cell Isolation from Endometrium and Menstrual Blood
  30. Poster Viewing Session IV
  31. Comparative capability of menstrual blood versus bone marrow derived stem cells in neural differentiation
  32. Differentiation potential of menstrual blood- versus bone marrow-stem cells into glial-like cells